tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Haemonetics price target lowered to $75 from $88 at Citi
PremiumThe FlyHaemonetics price target lowered to $75 from $88 at Citi
8d ago
Haemonetics reports Q3 adjusted EPS $1.31, consensus $1.25
Premium
The Fly
Haemonetics reports Q3 adjusted EPS $1.31, consensus $1.25
9d ago
Haemonetics narrows FY26 adjusted EPS view to $4.90-$5.00 from $4.80-$5.00
Premium
The Fly
Haemonetics narrows FY26 adjusted EPS view to $4.90-$5.00 from $4.80-$5.00
9d ago
Haemonetics acquires Vivasure to expand structural heart portfolio
PremiumCompany AnnouncementsHaemonetics acquires Vivasure to expand structural heart portfolio
1M ago
Haemonetics acquires Vivasure Medical for EUR 100M
Premium
The Fly
Haemonetics acquires Vivasure Medical for EUR 100M
1M ago
Haemonetics price target raised to $90 from $75 at Mizuho
Premium
The Fly
Haemonetics price target raised to $90 from $75 at Mizuho
2M ago
Haemonetics price target raised to $90 from $75 at BofA
PremiumThe FlyHaemonetics price target raised to $90 from $75 at BofA
2M ago
Haemonetics price target raised to $75 from $65 at Mizuho
Premium
The Fly
Haemonetics price target raised to $75 from $65 at Mizuho
3M ago
Haemonetics Reports Positive Earnings Call with Growth Highlights
Premium
Company Announcements
Haemonetics Reports Positive Earnings Call with Growth Highlights
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100